Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 1:194:377-385.
doi: 10.1016/j.drugalcdep.2018.10.027. Epub 2018 Nov 15.

A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife

Sean Esteban McCabe  1 , Philip T Veliz  2 , Carol J Boyd  3 , Ty S Schepis  4 , Vita V McCabe  5 , John E Schulenberg  6
Affiliations

A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife

Sean Esteban McCabe et al. Drug Alcohol Depend. .

Abstract

Background: This longitudinal study assesses characteristics associated with adolescents' nonmedical use of prescription opioids (NMUPO) including: frequency, co-ingestion, motives, specific opioid type; sequence of initiation of medical use of prescription opioids and NMUPO in relationship to subsequent substance use disorder (SUD) symptoms.

Methods: Twenty-one independent national cohorts of U.S. high school seniors (n = 8,373) were surveyed and followed 17 years from adolescence to age 35.

Results: The majority of adolescents who engaged in NMUPO reported occasional/frequent NMUPO, non-pain relief motives for NMUPO, simultaneous co-ingestion involving NMUPO and other drugs, opioid analgesics with high misuse potential, and multiple types of opioid analgesics. Adolescents who reported NMUPO for pain relief, NMUPO involving opioid analgesics with high misuse potential, or multiple prescription opioids had significantly greater odds of SUD symptoms at age 35, relative to those who had no history of NMUPO during adolescence. In addition, medical use of prescription opioids after initiating NMUPO (or NMUPO only) during adolescence was associated with significantly greater odds of subsequent SUD symptoms at age 35 relative to those who reported the medical use of prescription opioids only or had no medical use or NMUPO during adolescence.

Conclusions: This is the first U.S. national prospective study to examine the relationships between adolescents' NMUPO characteristics and later SUD symptoms in early midlife. Several characteristics (frequency, co-ingestion, motives, opioid type, and medical/NMUPO initiation history) were identified that could be used to screen and detect high-risk youth for indicated interventions to reduce prescription opioid misuse and SUDs.

Keywords: Co-ingestion; Longitudinal; Motivation; Prescription drug; Substance use disorder.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No conflict declared.

References

    1. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, fifth ed. American Psychiatric Publishing, Arlington, VA.
    1. Atluri S, Sudarshan G, Manchikanti L, 2014. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 17, E119–E128. - PubMed
    1. Bachman JG, Johnston LD, O’Malley PM, Schulenberg JE, Miech RA, 2015. The Monitoring the Future Project after Four Decades: Design and Procedures, Monitoring the Future Occasional Paper No. 82. University of Michigan Institute for Social Research, Ann Arbor, MI: http://monitoringthefuture.org/pubs/occpapers/mtf-occ82.pdf
    1. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC, 2011. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305, 1315–1321. - PubMed
    1. Bohnert ASB, Buy GP, Losby JL, 2018. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 opioid guideline. Ann. Intern. Med 169, 367–375. - PMC - PubMed

Publication types

Substances